Clinicalusedefinition-indication-example

FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-indication (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition

Resource ClinicalUseDefinition "example-indication"

StructureDefinition Work Group: brr

type: indication

subject: MedicinalProductDefinition/example

indication
DiseaseSymptomProcedures
- Concept
* Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults. (indicationasdisease-symptom-procedure#Pulmonary-embolism-and-thrombosis-example-code)
DiseaseStatuses
- Concept
* Recurrent (diseasestatus#Recurrent)
IntendedEffects
- Concept
* PRYLX (intendedeffect#PRYLX)

population:

type: person
membership: definitional
Characteristics
- Code Value[x] Exclude
* age-range (characteristic#age-range) 18-? a false

Generated Narrative: Group #group
type: person
membership: definitional
Characteristics
- Code Value[x] Exclude
* age-range (characteristic#age-range) 18-? a false

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.